Biogen Inc. buy Haans
Start price
24.10.16
/
50%
€261.98
Target price
24.04.17
€288.64
Performance (%)
3.34%
End price
24.04.17
€250.39
Summary
This prediction ended on 24.04.17 with a price of €250.39. With a performance of 3.34%, the BUY prediction by Haans for Biogen Inc. closed with a slight gain. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -3.457% | -3.457% | 2.089% | -45.522% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Biotech muss man nicht haben, aber man sollte...
Das Aufwärtsgap , von Ende Juli, wurde geschlossen, jetzt kann es wieder Richtung Norden gehen.
(Laufzeit überschritten)